.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Session Industry

Session Industry
Industrial Symposium UCB Pharma GmbH

Pro and contra of invasive therapies for the treatment of LGS

Appointment

Date: 19/09/2024

Time: 12:00 – 13:00

Location / Stream:

Lecture hall 1

Chair

Programme

12:00 – 12:30 30 Min. 0 Min.
Other
Epilepsy surgery may change the course of the disease in LGS
Susanne Schubert-Bast (Frankfurt a. M. / DE)
12:30 – 13:00 30 Min. 0 Min.
Other
Anti-seizure medications remain the mainstay of therapy in LGS
Adam Strzelczyk (Frankfurt a. M. / DE)

Session IndustryIndustrial Symposium UCB Pharma GmbH

Appointment

Chair

Programme

Session Industry
Industrial Symposium UCB Pharma GmbH